Passion, Voice and Experience for HIV Advocacy

A $600,000 “shady deal” at an amfAR fundraiser leads to investigations and resignations.

No. 5: As a 70-year-old white woman, I was one of the least likely people on the planet to contract HIV.

This finding applies to those with Child-Pugh A cirrhosis who are treated with the Viekira regimen or Technivie, with or without ribavirin.

The Global Network of People Living with HIV (GNP+) executive director seeks improved Greater Involvement of People Living with HIV/AIDS.

This finding falls in line with numerous analyses that show that PrEP’s benefits are largely not reaching Black gay and bi men.

Gilead Sciences’ second round of cure grants supports these five research projects.

Director Matthew Puccini talks about his film short “The Mess He Made.” The results aren’t what you expect.

Compared with the older tenofovir, called TDF, the new one, TAF, suppressed the virus as well and offered bone, kidney and lipid benefits.

A small study of Spanish people with HIV taking Prezista (darunavir) found that cholesterol and triglycerides dropped after the switch.